Oppenheimer analyst Brian Schwartz raised the firm's price target on Oracle (ORCL) to $235 from $210 and keeps an Outperform rating on the shares. The firm is also reiterating the name as its top pick, saying it sees positive developments during the current quarter that lend support to its superior EPS compounder thesis. Specifically, the strong technology infrastructure spending revealed in the Q1 reports from Oracle's largest customers, partners, and suppliers combined with a significant restructuring announcement on March 31 bode well for potential upside in the Q4 2026 results next month and bolster the medium-term financials guidance, in Oppenheimer's view. Furthermore, the firm expects solid bookings growth in Q4 from OpenAI, Meta (META), Nvidia (NVDA) and federal government commitments, Microsoft (MSFT) outsourcing its lower margin training business to Oracle, and demand uplift from the positive seasonality for the broader Oracle product portfolio.
